How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

28,518 results for

Topical Corticosteroid

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Prescribing for rheumatological conditions in pregnancy and breastfeeding - Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Full Text available with Trip Pro

Prescribing for rheumatological conditions in pregnancy and breastfeeding - Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs (...) and corticosteroids | Rheumatology | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close mobile search navigation Article navigation September 2016 Article Contents Article Navigation BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids Julia Flint 1 Centre for Rheumatology Research, UCL Division of Medicine

2016 British Society for Rheumatology

122. Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis Full Text available with Trip Pro

Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis Patients suffering from allergic rhinitis often attempt to self-manage their symptoms and may seek advice from pharmacists about nonprescription product choices. Several drug classes, both prescription and over-the-counter (OTC), are available, including intranasal corticosteroids (INCSs); oral, intranasal, and ocular antihistamines; leukotriene antagonists; and topical and systemic

2017 Integrated pharmacy research & practice

123. Corticosteroid treatment of duchenne muscular dystrophy

Corticosteroid treatment of duchenne muscular dystrophy Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy | Neurology Advertisement Search for this keyword Main menu User menu Search Search for this keyword The most widely read and highly cited peer-reviewed neurology journal Share February 02, 2016 ; 86 (5) Special Article Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy Report of the Guideline Development (...) .), Loma Linda University Medical Center, CA; and Departments of Pediatric and Neurology/Neurosurgery (M.O.), McGill University, Montréal, Canada. Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy David Gloss , Richard T. Moxley , Stephen Ashwal , Maryam Oskoui Neurology Feb 2016, 86 (5) 465-472; DOI: 10.1212/WNL.0000000000002337 Citation Manager Formats Make Comment See Comments Downloads 5504 Share Abstract Objective: To update the 2005 American Academy

2016 American Academy of Neurology

124. Alternatives to systemic postnatal corticosteroids: Inhaled, nebulized and intratracheal. (Abstract)

Alternatives to systemic postnatal corticosteroids: Inhaled, nebulized and intratracheal. Concern about adverse outcomes with the use of systemic postnatal corticosteroids (PCS) for bronchopulmonary dysplasia (BPD) have led to the widespread use of alternative methods of administration in research and clinical care. Theoretically, administration of topical (directly to the lung) corticosteroids may allow for beneficial effects on the pulmonary system with a lower risk of undesirable side (...) effects compared with systemic administration. Current evidence suggests that inhaled corticosteroids may be an effective therapy in the management of developing BPD in preterm infants, but questions about their safety remain. An alternative to inhalation is the intratracheal administration of corticosteroids using surfactant as a vehicle, but this approach has only been studied in a limited number of infants. We review the evidence for the short-term clinical efficacy and safety of inhaled, nebulized

2019 Seminars in fetal & neonatal medicine

125. Preliminary Report on the Role of Dry Needling Versus Corticosteroid Injection, an Effective Treatment Method for Plantar Fasciitis: A Randomized Controlled Trial. (Abstract)

Preliminary Report on the Role of Dry Needling Versus Corticosteroid Injection, an Effective Treatment Method for Plantar Fasciitis: A Randomized Controlled Trial. Plantar fasciopathy (PF) is a common disorder for which there is no consensus regarding an optimal treatment strategy. We hypothesized that dry needling would be as effective as the use of corticosteroid injections for treating PF while avoiding the potential adverse effects of corticosteroids. After approval was received from (...) the institutional review board, patients diagnosed with PF were prescribed a 3-week nonoperative treatment regimen. In addition to using oral and topical antiinflammatory drugs, patients engaged in plantar fascia and gastrocnemius stretching exercises. A study population of 98 patients was planned. An appointment was made in the third week of first-line treatment. Patients whose pain did not abate and who required further treatment were included in the study. One week later, we randomly divided patients into 2

2019 The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons Controlled trial quality: uncertain

126. Stable Ozonides with Vitamin E Acetate versus Corticosteroid in the Treatment of Lichen Sclerosus in Foreskin: Evaluation of Effects on Inflammation. (Abstract)

Stable Ozonides with Vitamin E Acetate versus Corticosteroid in the Treatment of Lichen Sclerosus in Foreskin: Evaluation of Effects on Inflammation. Lichen sclerosus (LS) is a disease of the skin of unclear etiology that can occur in the foreskin. Topical therapy with corticosteroids is recommended, but they can have side effects.We aimed to compare the effects of ozonides with vitamin E acetate (OZOILE) versus topical corticosteroid in children undergoing circumcision.Twenty children (...) undergoing circumcision were treated before surgery: 10 children with OZOILE cream and 10 with 0.1% mometasone furoate once a day for 7 days. Ten age-matched patients with LS of the foreskin without any treatment were recruited as controls. Transcript levels of proinflammatory and anti-inflammatory cytokines and e-cadherin were evaluated in removed foreskins by qRT-PCR.OZOILE and steroid topical treatment produced a similar reduction of TNF-α and IL-1β mRNA levels in foreskins from patients with LS when

2019 Urologia internationalis Controlled trial quality: uncertain

127. Assessing the Effect of Clinical Trial Evidence and Anecdote on Caregivers' Willingness to Use Corticosteroids: A Randomized Controlled Trial. (Abstract)

Assessing the Effect of Clinical Trial Evidence and Anecdote on Caregivers' Willingness to Use Corticosteroids: A Randomized Controlled Trial. Treatment of childhood atopic dermatitis (AD) is hindered by nonadherence, but caregiver reassurance may help overcome this hurdle.To assess caregivers' willingness to treat childhood AD with a corticosteroid when presented with clinical trial evidence, anecdote, or both.A total of 476 caregivers were recruited through a dermatology clinic and online (...) crowdsourcing platform. Subjects were randomized to receive clinical trial evidence, anecdote, or both, using either the term "medication" or "topical steroid." Additional caregivers were queried about their willingness to treat with the doctor's recommendation or without knowledge of its safety information. Responses were recorded on a 10-point Likert scale.Caregivers' willingness to treat was higher in all information assignment groups compared to those not provided with safety information: clinical trial

2019 Journal of cutaneous medicine and surgery Controlled trial quality: uncertain

128. Efficacy and cost savings with the use of a minimal sedation / anxiolysis protocol for intra-articular corticosteroid injections in children with juvenile idiopathic arthritis: a retrospective review of prospectively collected data. Full Text available with Trip Pro

reported, and no patients progressed to a deeper level of sedation than intended. Financial analysis revealed a 33% cost reduction compared with the use of general anesthesia in the operating room.A minimal sedation/anxiolysis protocol (including nitrous oxide, intranasal fentanyl, a topical numbing agent, acetaminophen, ibuprofen, ondansetron and child life intervention), provides safe and effective analgesia for intra-articular corticosteroid injection in a subset of patients with juvenile idiopathic (...) Efficacy and cost savings with the use of a minimal sedation / anxiolysis protocol for intra-articular corticosteroid injections in children with juvenile idiopathic arthritis: a retrospective review of prospectively collected data. Intra-articular corticosteroid injections (IACI) are frequently used in the treatment of juvenile idiopathic arthritis. There is a paucity of evidence-based research describing methods of pain and anxiety control for this procedure. IACI were mostly performed under

2019 Pediatric Rheumatology

129. Predictive Factors in Response to Inhaled Corticoids in Chronic Cough

Predictive Factors in Response to Inhaled Corticoids in Chronic Cough Predictive Factors in Response to Inhaled Corticoids in Chronic Cough - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Predictive Factors (...) in Response to Inhaled Corticoids in Chronic Cough (FeNOTX) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02715167 Recruitment Status : Unknown Verified March 2016 by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Recruitment status was: Not yet recruiting First Posted : March 22

2016 Clinical Trials

130. Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers.

Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Diprophos Patients having had a sprain of the long fingers, within 2 weeks of consultation. This group will receive a single injection of corticoids. Drug: Diprophos Single subcutaneous injection of Diprophos, in the acute phase. No Intervention: Control group Patients having had a sprain of the long fingers (Eaton classification type I and II), within 2 weeks of consultation. This group (...) Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers. Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2016 Clinical Trials

131. A Randomized, Split-Face, Controlled, Double-Blind, Single-Center Clinical Study: Transient Addition of a Topical Corticosteroid to a Topical Retinoid in Acne Patients to Reduce Initial Irritation. (Abstract)

, Roanoke, VA, 24016, U.S.A. Chavan R N RN Division of Dermatology, Department of Medicine, Virginia Tech Carilion School of Medicine, Suite 300, 1 Riverside Circle, Roanoke, VA, 24016, U.S.A. Kolodney M S MS Department of Dermatology, West Virginia University, P.O. Box 9158, Morgantown, WV, 26506-9158, U.S.A. eng Letter Randomized Controlled Trial 2017 06 29 England Br J Dermatol 0004041 0007-0963 0 Adrenal Cortex Hormones 0 Dermatologic Agents 0 Lipids 1ZK20VI6TY Triamcinolone 5688UTC01R Tretinoin (...) 8036-49-5 eucerin IM Acne Vulgaris drug therapy Administration, Cutaneous Adolescent Adrenal Cortex Hormones administration & dosage Adult Child Dermatitis, Irritant prevention & control Dermatologic Agents administration & dosage Double-Blind Method Facial Dermatoses drug therapy Female Humans Lipids administration & dosage Male Middle Aged Patient Satisfaction Tretinoin administration & dosage Triamcinolone administration & dosage Young Adult 2016 10 28 6 0 2018 8 7 6 0 2016 10 28 6 0 ppublish

2016 British Journal of Dermatology Controlled trial quality: uncertain

132. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. Full Text available with Trip Pro

Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. Many clinicians have concerns about the safety of atopic dermatitis (AD) treatments, particularly in children requiring long-term daily maintenance therapy. Topical corticosteroids (TCS) have been widely used for >5 decades. Long-term TCS monotherapy has been associated with adverse cutaneous effects including atrophy, rebound flares (...) , and increased percutaneous absorption with potential for adverse systemic effects. Topical calcineurin inhibitors (TCIs), tacrolimus and pimecrolimus, available for 1-2 decades, are not associated with atrophy or increased percutaneous absorption after prolonged use and have much lower potential for systemic effects. However, since 2006 TCIs have carried a controversial Boxed Warning based on a theoretical risk of malignancy (eg, skin and lymphoma) that has limited TCI use for standard-of-care maintenance

2016 BMC pediatrics

133. Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience. (Abstract)

Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience. Calcineurin inhibitors are alternatives to corticosteroid for treatment of atopic dermatitis.We sought to compare the beneficial effects and adverse events associated with these therapies in treating patients with atopic dermatitis.Four databases were searched for randomized clinical trials comparing topical (...) calcineurin inhibitors versus corticosteroids in children and adults. Methodological quality was evaluated to assess bias risk. Clinical outcome and costs were compared.Twelve independent randomized clinical trials comparing calcineurin inhibitors (n = 3492) versus corticosteroids (n = 3462) were identified. Calcineurin inhibitors and corticosteroids had similar rates of improvement of dermatitis (81% vs 71%; risk ratio [RR] 1.18; 95% confidence interval [CI] 1.04-1.34; P = .01) and treatment success (72

2016 Journal of the American Academy of Dermatology

134. Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases. Full Text available with Trip Pro

Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases. Infantile hemangioma (IH) may have implications on parental distress and cosmetic disfigurement. To date, ultrapotent corticosteroids are used as a treatment of choice for superficial IH. However, due to their side effects and sometimes lack of IH regression, it is necessary to find alternative topical therapies. Timolol maleate 0.5 (...) % solution and gel are nonselective β-blockers that could inhibit proliferation and trigger regression of IH.To evaluate the efficacy of topical ultrapotent corticosteroids and timolol maleate 0.5% solution and gel for superficial IH.The study design was prospective. Two hundred and seventy-eight patients diagnosed as having superficial IH were enrolled from the outpatient clinic of the Department of Dermatology and Venereology, Dr. Sardjito Hospital, Yogyakarta, Indonesia, from January 2009 to December

2016 Dermatology

135. Corticosteroids - oral

No NICE quality standards were found during the review of this topic. Background information Background information Definition What are corticosteroids? Corticosteroids are synthetic analogues of hormones that are produced by the adrenal cortex. Synthetic corticosteroids can have glucocorticoid and/or mineralocorticoid properties. Glucocorticoid properties are anti-inflammatory, immunosuppressive, anti-proliferative, and vasoconstrictive. Glucocorticoid properties also support a variety of metabolic (...) Corticosteroids - oral Corticosteroids - oral - NICE CKS Share Corticosteroids - oral: Summary Corticosteroids are synthetic analogues of hormones produced by the adrenal cortex. Corticosteroids are either high in glucocorticoid or mineralocorticoid activity. Oral corticosteroids with a high glucocorticoid activity are: Betamethasone. Cortisone. Deflazacort. Dexamethasone. Hydrocortisone. Methylprednisolone. Prednisolone. Fludrocortisone acetate is an oral corticosteroid with a high

2017 NICE Clinical Knowledge Summaries

136. A retrospective analysis of pediatric patients with lichen sclerosus treated with a standard protocol of class I topical corticosteroid and topical calcineurin inhibitor. (Abstract)

A retrospective analysis of pediatric patients with lichen sclerosus treated with a standard protocol of class I topical corticosteroid and topical calcineurin inhibitor. Lichen sclerosus (LS) is a chronic, inflammatory condition of the skin, affecting primarily the anogenital region potentially leading to changes in vaginal architecture and vulvar squamous cell carcinoma. Current recommended treatment for LS is high-potency corticosteroids. Calcineurin inhibitors may also have a role.The (...) objective of this study is to introduce a treatment regimen involving clobetasol to induce remission, then tacrolimus to maintain remission in pediatric females with LS.As a retrospective case series, we report 14 pediatric females between 2 and 10 years of age with LS treated with clobetasol 0.05% topical ointment and systematically bridged to tacrolimus 0.1% topical ointment. For each patient, gender, age at disease onset, and clinical symptoms and features were noted. Time in weeks to 75% clearance

2015 Journal of Dermatological Treatment

137. Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata

Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata (COLA) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02350023 Recruitment Status : Completed First Posted : January 29, 2015 Last Update Posted

2015 Clinical Trials

138. Efficacy of interventions to improve adherence to inhaled corticosteroids in adult asthmatics: impact of using components of the chronic care model Full Text available with Trip Pro

Quebec. Bibliographic details Moullec G, Gour-Provencal G, Bacon SL, Campbell TS, Lavoie KL. Efficacy of interventions to improve adherence to inhaled corticosteroids in adult asthmatics: impact of using components of the chronic care model. Respiratory Medicine 2012; 106(9): 1211-1225 PubMedID DOI Original Paper URL Indexing Status Subject indexing assigned by NLM MeSH Administration, Inhalation; Adrenal Cortex Hormones /administration & Adult; Aged; Anti-Asthmatic Agents /administration & Asthma (...) Efficacy of interventions to improve adherence to inhaled corticosteroids in adult asthmatics: impact of using components of the chronic care model Efficacy of interventions to improve adherence to inhaled corticosteroids in adult asthmatics: impact of using components of the chronic care model Efficacy of interventions to improve adherence to inhaled corticosteroids in adult asthmatics: impact of using components of the chronic care model Moullec G, Gour-Provencal G, Bacon SL, Campbell TS

2012 DARE.

139. Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical corticosteroids with moisturizers for children (< 2 years old) with atopic dermatitis

Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical corticosteroids with moisturizers for children (< 2 years old) with atopic dermatitis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2017 PROSPERO

140. Inhaled Corticosteroids for Treatment of Bronchopulmonary Dysplasia

Inhaled Corticosteroids for Treatment of Bronchopulmonary Dysplasia Inhaled Corticosteroids for Treatment of Bronchopulmonary Dysplasia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Inhaled (...) Corticosteroids for Treatment of Bronchopulmonary Dysplasia The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03503994 Recruitment Status : Completed First Posted : April 20, 2018 Last Update Posted : April 20, 2018 Sponsor: Mount Sinai Hospital, Canada Collaborators: Sunnybrook Health Sciences Centre IWK Health

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>